Steven Lo
Chief Executive Officer at VAXART, INC.
Profile
Steven Lo's current job is as the President, Chief Executive Officer & Director at Vaxart, Inc. He previously worked as the Chief Executive Officer & Director at Valitor, Inc. from 2022 to 2024, and as the President, Chief Executive Officer & Director at Zosano Pharma Corp.
from 2019 to 2022.
Prior to that, he held the position of Senior Director-Oncology Marketing at Genentech, Inc. from 1997 to 2010.
He also served as the Chief Commercial Officer & Senior Vice President at Corcept Therapeutics, Inc. from 2013 to 2015, and as the Chief Commercial Officer at Puma Biotechnology, Inc. from 2015 to 2019.
Mr. Lo's education includes a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Davis.
Steven Lo active positions
| Companies | Position | Start |
|---|---|---|
| VAXART, INC. | Chief Executive Officer | 2024-03-17 |
Former positions of Steven Lo
| Companies | Position | End |
|---|---|---|
Valitor, Inc.
 Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Chief Executive Officer | 2024-02-29 |
| ZOSANO PHARMA CORPORATION | Chief Executive Officer | 2022-07-31 |
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 2019-10-03 |
| CORCEPT THERAPEUTICS INCORPORATED | Corporate Officer/Principal | 2015-09-03 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Steven Lo
| University of California, Davis | Undergraduate Degree |
| University of Southern California | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Kaiser Permanente Washington Health Research Institute
 Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | Health Services |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Steven Lo
